Alexandria Real Estate Equities Inc
NYSE:ARE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
97.29
129.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Alexandria Real Estate Equities Inc
Alexandria Real Estate Equities Inc
Cost of Revenue
Alexandria Real Estate Equities Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Alexandria Real Estate Equities Inc
NYSE:ARE
|
Cost of Revenue
-$891.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-15%
|
|
|
Boston Properties Inc
NYSE:BXP
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Kilroy Realty Corp
NYSE:KRC
|
Cost of Revenue
-$358.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Vornado Realty Trust
NYSE:VNO
|
Cost of Revenue
-$911.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Cousins Properties Inc
NYSE:CUZ
|
Cost of Revenue
-$273.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
COPT Defense Properties
NYSE:CDP
|
Cost of Revenue
-$334.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Alexandria Real Estate Equities Inc
Glance View
In the bustling hub of urban life sciences and technology campuses, Alexandria Real Estate Equities Inc. has carved a niche that integrates real estate acumen with a deep understanding of the life sciences industry. Born in 1994, it emerged as a visionary undertaking, keenly focused on serving the unique needs of life sciences enterprises by providing strategically located and highly sophisticated laboratory and office spaces. Headquartered in Pasadena, California, Alexandria has built a reputation not just as a landlord, but as a partner to a broad spectrum of innovative tenants ranging from biotech startups to global pharmaceutical giants. The company’s properties are primarily located in top innovation clusters like Greater Boston, San Francisco Bay Area, New York City, and San Diego, ensuring close proximity to leading research institutions and talent pools. Alexandria’s business model thrives on a keen strategy of acquiring, developing, and operating properties in these sought-after corridors, where science and technology entrepreneurship flourishes. The company generates revenue through leasing its carefully curated real estate portfolio, with rental income forming the backbone of its financial success. Each property is designed or upgraded to meet the demanding requirements of its tenants, often including state-of-the-art laboratory facilities and amenities that foster collaboration and innovation. This not only enables Alexandria to command premium lease rates but also helps maintain high occupancy levels. The uniqueness of its properties and strategic presence in dynamic markets provide Alexandria with a strong competitive edge, underpinning its growth and establishing its stature in the specialized domain of life sciences real estate investment trusts (REITs).
See Also
What is Alexandria Real Estate Equities Inc's Cost of Revenue?
Cost of Revenue
-891.6m
USD
Based on the financial report for Sep 30, 2024, Alexandria Real Estate Equities Inc's Cost of Revenue amounts to -891.6m USD.
What is Alexandria Real Estate Equities Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-15%
Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for Alexandria Real Estate Equities Inc have been -15% over the past three years , -16% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
